 | • レポートコード：GIR-105X09829 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、日本脳炎ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。日本脳炎ワクチンの種類別市場規模（生ワクチン、不活化ワクチン）、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・日本脳炎ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi Pasteur、GlaxoSmithKline、Bharat Biotech、China National Biotec Group、Valneva Products ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：生ワクチン、不活化ワクチン ・用途別分析2016年-2026年：大人、子供 ・日本脳炎ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・日本脳炎ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・日本脳炎ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・日本脳炎ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・日本脳炎ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Japanese Encephalitis Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Japanese Encephalitis Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Japanese Encephalitis Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Japanese Encephalitis Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Attenuated Vaccines
Inactivated Vaccines
Market segment by Application can be divided into
Adults
Children
The key market players for global Japanese Encephalitis Vaccines market are listed below:
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
China National Biotec Group
Valneva Products
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Japanese Encephalitis Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Japanese Encephalitis Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Japanese Encephalitis Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Children
1.4 Global Japanese Encephalitis Vaccines Market Size & Forecast
1.4.1 Global Japanese Encephalitis Vaccines Sales in Value (2016-2026))
1.4.2 Global Japanese Encephalitis Vaccines Sales in Volume (2016-2026)
1.4.3 Global Japanese Encephalitis Vaccines Price by Type (2016-2026) & (USD/Dose)
1.5 Global Japanese Encephalitis Vaccines Production Capacity Analysis
1.5.1 Global Japanese Encephalitis Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Japanese Encephalitis Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Japanese Encephalitis Vaccines Market Drivers
1.6.2 Japanese Encephalitis Vaccines Market Restraints
1.6.3 Japanese Encephalitis Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Product and Services
2.1.4 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Product and Services
2.2.4 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bharat Biotech
2.3.1 Bharat Biotech Details
2.3.2 Bharat Biotech Major Business
2.3.3 Bharat Biotech Japanese Encephalitis Vaccines Product and Services
2.3.4 Bharat Biotech Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 China National Biotec Group
2.4.1 China National Biotec Group Details
2.4.2 China National Biotec Group Major Business
2.4.3 China National Biotec Group Japanese Encephalitis Vaccines Product and Services
2.4.4 China National Biotec Group Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Valneva Products
2.5.1 Valneva Products Details
2.5.2 Valneva Products Major Business
2.5.3 Valneva Products Japanese Encephalitis Vaccines Product and Services
2.5.4 Valneva Products Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Japanese Encephalitis Vaccines Sales by Manufacturer
3.1 Global Japanese Encephalitis Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Japanese Encephalitis Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Japanese Encephalitis Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Japanese Encephalitis Vaccines Manufacturer Market Share
3.4.2 Top 6 Japanese Encephalitis Vaccines Manufacturer Market Share
3.5 Global Japanese Encephalitis Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Japanese Encephalitis Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Japanese Encephalitis Vaccines Market Size by Region
4.1.1 Global Japanese Encephalitis Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Japanese Encephalitis Vaccines Revenue by Region (2016-2026)
4.2 North America Japanese Encephalitis Vaccines Revenue (2016-2026)
4.3 Europe Japanese Encephalitis Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Japanese Encephalitis Vaccines Revenue (2016-2026)
4.5 South America Japanese Encephalitis Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Japanese Encephalitis Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Japanese Encephalitis Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Japanese Encephalitis Vaccines Revenue by Type (2016-2026)
5.3 Global Japanese Encephalitis Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Japanese Encephalitis Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Japanese Encephalitis Vaccines Revenue by Application (2016-2026)
6.3 Global Japanese Encephalitis Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Japanese Encephalitis Vaccines Sales by Type (2016-2026)
7.2 North America Japanese Encephalitis Vaccines Sales by Application (2016-2026)
7.3 North America Japanese Encephalitis Vaccines Market Size by Country
7.3.1 North America Japanese Encephalitis Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Japanese Encephalitis Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Japanese Encephalitis Vaccines Sales by Type (2016-2026)
8.2 Europe Japanese Encephalitis Vaccines Sales by Application (2016-2026)
8.3 Europe Japanese Encephalitis Vaccines Market Size by Country
8.3.1 Europe Japanese Encephalitis Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Japanese Encephalitis Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Japanese Encephalitis Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Japanese Encephalitis Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Japanese Encephalitis Vaccines Market Size by Region
9.3.1 Asia-Pacific Japanese Encephalitis Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Japanese Encephalitis Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Japanese Encephalitis Vaccines Sales by Type (2016-2026)
10.2 South America Japanese Encephalitis Vaccines Sales by Application (2016-2026)
10.3 South America Japanese Encephalitis Vaccines Market Size by Country
10.3.1 South America Japanese Encephalitis Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Japanese Encephalitis Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Japanese Encephalitis Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Japanese Encephalitis Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Japanese Encephalitis Vaccines Market Size by Country
11.3.1 Middle East & Africa Japanese Encephalitis Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Japanese Encephalitis Vaccines Typical Distributors
12.3 Japanese Encephalitis Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Japanese Encephalitis Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Japanese Encephalitis Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Japanese Encephalitis Vaccines Product and Services
Table 6. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Japanese Encephalitis Vaccines Product and Services
Table 10. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 12. Bharat Biotech Major Business
Table 13. Bharat Biotech Japanese Encephalitis Vaccines Product and Services
Table 14. Bharat Biotech Japanese Encephalitis Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table 16. China National Biotec Group Major Business
Table 17. China National Biotec Group Japanese Encephalitis Vaccines Product and Services
Table 18. China National Biotec Group Japanese Encephalitis Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Valneva Products Basic Information, Manufacturing Base and Competitors
Table 20. Valneva Products Major Business
Table 21. Valneva Products Japanese Encephalitis Vaccines Product and Services
Table 22. Valneva Products Japanese Encephalitis Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Japanese Encephalitis Vaccines Sales by Manufacturer (2019-2021e) & (K Doses)
Table 24. Global Japanese Encephalitis Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Japanese Encephalitis Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Japanese Encephalitis Vaccines Production Capacity by Company, (K Doses): 2020 VS 2021
Table 27. Head Office and Japanese Encephalitis Vaccines Production Site of Key Manufacturer
Table 28. Global Japanese Encephalitis Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 29. Global Japanese Encephalitis Vaccines Sales by Region (2021-2026) & (K Doses)
Table 30. Global Japanese Encephalitis Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Japanese Encephalitis Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Japanese Encephalitis Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 33. Global Japanese Encephalitis Vaccines Sales by Type (2021-2026) & (K Doses)
Table 34. Global Japanese Encephalitis Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Japanese Encephalitis Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Japanese Encephalitis Vaccines Price by Type (2016-2021e) & (USD/Dose)
Table 37. Global Japanese Encephalitis Vaccines Price by Type (2021-2026) & (USD/Dose)
Table 38. Global Japanese Encephalitis Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 39. Global Japanese Encephalitis Vaccines Sales by Application (2021-2026) & (K Doses)
Table 40. Global Japanese Encephalitis Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Japanese Encephalitis Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Japanese Encephalitis Vaccines Price by Application (2016-2021e) & (USD/Dose)
Table 43. Global Japanese Encephalitis Vaccines Price by Application (2021-2026) & (USD/Dose)
Table 44. North America Japanese Encephalitis Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 45. North America Japanese Encephalitis Vaccines Sales by Country (2021-2026) & (K Doses)
Table 46. North America Japanese Encephalitis Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Japanese Encephalitis Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Japanese Encephalitis Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 49. North America Japanese Encephalitis Vaccines Sales by Type (2021-2026) & (K Doses)
Table 50. North America Japanese Encephalitis Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 51. North America Japanese Encephalitis Vaccines Sales by Application (2021-2026) & (K Doses)
Table 52. Europe Japanese Encephalitis Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 53. Europe Japanese Encephalitis Vaccines Sales by Country (2021-2026) & (K Doses)
Table 54. Europe Japanese Encephalitis Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Japanese Encephalitis Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Japanese Encephalitis Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 57. Europe Japanese Encephalitis Vaccines Sales by Type (2021-2026) & (K Doses)
Table 58. Europe Japanese Encephalitis Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 59. Europe Japanese Encephalitis Vaccines Sales by Application (2021-2026) & (K Doses)
Table 60. Asia-Pacific Japanese Encephalitis Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 61. Asia-Pacific Japanese Encephalitis Vaccines Sales by Region (2021-2026) & (K Doses)
Table 62. Asia-Pacific Japanese Encephalitis Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Japanese Encephalitis Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Japanese Encephalitis Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 65. Asia-Pacific Japanese Encephalitis Vaccines Sales by Type (2021-2026) & (K Doses)
Table 66. Asia-Pacific Japanese Encephalitis Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 67. Asia-Pacific Japanese Encephalitis Vaccines Sales by Application (2021-2026) & (K Doses)
Table 68. South America Japanese Encephalitis Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 69. South America Japanese Encephalitis Vaccines Sales by Country (2021-2026) & (K Doses)
Table 70. South America Japanese Encephalitis Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Japanese Encephalitis Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Japanese Encephalitis Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 73. South America Japanese Encephalitis Vaccines Sales by Type (2021-2026) & (K Doses)
Table 74. South America Japanese Encephalitis Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 75. South America Japanese Encephalitis Vaccines Sales by Application (2021-2026) & (K Doses)
Table 76. Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 77. Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2021-2026) & (K Doses)
Table 78. Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Japanese Encephalitis Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 81. Middle East & Africa Japanese Encephalitis Vaccines Sales by Type (2021-2026) & (K Doses)
Table 82. Middle East & Africa Japanese Encephalitis Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 83. Middle East & Africa Japanese Encephalitis Vaccines Sales by Application (2021-2026) & (K Doses)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Japanese Encephalitis Vaccines Typical Distributors
Table 87. Japanese Encephalitis Vaccines Typical Customers
List of Figures
Figure 1. Japanese Encephalitis Vaccines Picture
Figure 2. Global Japanese Encephalitis Vaccines Sales Market Share by Type in 2020
Figure 3. Attenuated Vaccines
Figure 4. Inactivated Vaccines
Figure 5. Global Japanese Encephalitis Vaccines Sales Market Share by Application in 2020
Figure 6. Adults
Figure 7. Children
Figure 8. Global Japanese Encephalitis Vaccines Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 9. Global Japanese Encephalitis Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Japanese Encephalitis Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Japanese Encephalitis Vaccines Sales (2016-2026) & (K Doses)
Figure 30. Global Japanese Encephalitis Vaccines Production Capacity (2016-2026) & (K Doses)
Figure 31. Global Japanese Encephalitis Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Japanese Encephalitis Vaccines Market Drivers
Figure 33. Japanese Encephalitis Vaccines Market Restraints
Figure 34. Japanese Encephalitis Vaccines Market Trends
Figure 35. Global Japanese Encephalitis Vaccines Sales Market Share by Manufacturer in 2020
Figure 36. Global Japanese Encephalitis Vaccines Revenue Market Share by Manufacturer in 2020
Figure 37. Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Japanese Encephalitis Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Japanese Encephalitis Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2016-2026)
Figure 41. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2016-2026)
Figure 42. North America Japanese Encephalitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 43. Europe Japanese Encephalitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Japanese Encephalitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. South America Japanese Encephalitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Japanese Encephalitis Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2016-2026)
Figure 48. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2016-2026)
Figure 49. Global Japanese Encephalitis Vaccines Price by Type (2016-2026) & (USD/Dose)
Figure 50. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2016-2026)
Figure 51. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2016-2026)
Figure 52. Global Japanese Encephalitis Vaccines Price by Application (2016-2026) & (USD/Dose)
Figure 53. North America Japanese Encephalitis Vaccines Sales Market Share by Country (2016-2026)
Figure 54. North America Japanese Encephalitis Vaccines Revenue Market Share by Country (2016-2026)
Figure 55. North America Japanese Encephalitis Vaccines Sales Market Share by Type (2016-2026)
Figure 56. North America Japanese Encephalitis Vaccines Sales Market Share by Application (2016-2026)
Figure 57. Europe Japanese Encephalitis Vaccines Sales Market Share by Country (2016-2026)
Figure 58. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country (2016-2026)
Figure 59. Europe Japanese Encephalitis Vaccines Sales Market Share by Type (2016-2026)
Figure 60. Europe Japanese Encephalitis Vaccines Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Japanese Encephalitis Vaccines Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Japanese Encephalitis Vaccines Sales Market Share by Application (2016-2026)
Figure 65. South America Japanese Encephalitis Vaccines Sales Market Share by Country (2016-2026)
Figure 66. South America Japanese Encephalitis Vaccines Revenue Market Share by Country (2016-2026)
Figure 67. South America Japanese Encephalitis Vaccines Sales Market Share by Type (2016-2026)
Figure 68. South America Japanese Encephalitis Vaccines Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Japanese Encephalitis Vaccines Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
日本脳炎ワクチンの世界市場2018-2025 Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. How long this protection lasts is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.…- ヒト混合ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are eith…
- 世界のジフテリアワクチン市場 2021：企業別、地域別、種類・用途別 The Diphtheria Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 抗感染ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Anti-infective vaccines are the most effective public health measure taken to fight infectious diseases. Scope of the Report: This report focuses on the Anti-Infective Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report …
- 獣医ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. Scope of the Report: This report focuses on the Veterinary Vaccines in global market, especially in North America, Europe and Asia-Pacific,…